Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01283022 · ClinicalTrials.gov registry record · Phase 2
Pharmacokinetic (PK) Study of the 200 Microgram (mcg) Misoprostol Vaginal Insert (MVI 200) in Women at Term Gestation (The MVI-PK Study)
A Phase 2 study of Cervical Ripening and Induction of Labor, sponsored by Ferring Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT01283022 is a Phase 2 study of Cervical Ripening and Induction of Labor that has completed, run by Ferring Pharmaceuticals. The registered enrollment target is 24 participants, below the 468-participant average among 8 other Cervical Ripening trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01283022, a Phase 2 study of Cervical Ripening and Induction of Labor, has completed, sponsored by Ferring Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the pharmacokinetics (PK) of misoprostol acid for the MVI 200 in women requiring cervical ripening and induction of labor.
Conditions Studied
Interventions
- DRUG MVI 200
Study Locations (1)
California
- Huntington Memorial Hospital - Pasadena
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2011-05 |
| Est. Completion | 2011-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01283022
The ClinicalTrials.gov registry entry for NCT01283022 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 468-participant average among 8 other Cervical Ripening trials with a reported enrollment target (95% lower). The listed sponsor is Ferring Pharmaceuticals, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cervical Ripening appearing as the primary indexed condition, and to 1 intervention - of which MVI 200 is the first listed.
NCT01283022 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01283022 about?
NCT01283022 is a clinical study titled "Pharmacokinetic (PK) Study of the 200 Microgram (mcg) Misoprostol Vaginal Insert (MVI 200) in Women at Term Gestation (The MVI-PK Study)". The purpose of this study is to determine the pharmacokinetics (PK) of misoprostol acid for the MVI 200 in women requiring cervical ripening and induction of labor.
What is the current status of trial NCT01283022?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2011-05. Estimated completion is 2011-07.
What conditions does trial NCT01283022 study?
This clinical trial studies the following conditions: Cervical Ripening, Induction of Labor.
What interventions are being tested in trial NCT01283022?
The interventions under investigation include: MVI 200 (DRUG).
Who is sponsoring clinical trial NCT01283022?
This trial is sponsored by Ferring Pharmaceuticals, which has 83 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01283022 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Ripening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Misoprostol Vaginal Insert (MVI) 100, 150, 200 mcg for Cervical Ripening and Induction of Labor
COMPLETED · Phase 2
-
Randomized Trial Comparing Misoprostol and Foley Bulb for Labor Induction in the Preterm Gestation
COMPLETED · Phase 2
-
Patient Satisfaction During Outpatient Versus Inpatient Foley Catheter Induction of Labor
COMPLETED · NA
-
Foley Catheter Compared to the Foley Catheter Alone for Cervical Ripening
COMPLETED · NA
-
Study of the Effectiveness of Cervical Ripening Balloon With and Without Oxytocin
COMPLETED · Phase 3
-
Efficacy & Safety Study Comparing Misoprostol Vaginal Insert (MVI) Versus Dinoprostone Vaginal Insert (DVI) for Reducing Time to Vaginal Delivery
COMPLETED · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.